Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FYX50
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $247,247
Award facts
- Contract value 100% obligated
- $247,246.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $247,246.50 to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver this pharmaceutical product with a firm fixed price contract type and an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, allowing the vendor to compete on an unrestricted basis in the federal procurement market.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026 under the SPE2DB program. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and specialty medications to Department of Defense healthcare sites, with Entyvio representing one component of the company's extensive portfolio of branded and generic pharmaceutical products, biologics, and medical consumables.
Quick answers
Who was awarded contract SPE2DB25FYX50?
SPE2DB25FYX50 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FYX50 worth?
The government has obligated $247,247 on SPE2DB25FYX50.
Is contract SPE2DB25FYX50 an order under another contract?
Yes. SPE2DB25FYX50 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX50 competed?
The extent of competition for SPE2DB25FYX50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award